Clive Cookson – Financial Times, 02/13/2016
The global pharmaceutical and bioscience industry has responded swiftly to the Zika epidemic, with 15 companies involved in vaccine development and 20 in making diagnostic tests for the mosquito-borne virus, which is associated with birth defects.
In update briefings in Geneva and Washington on Friday, senior officials from the World Health Organisation and the US National Institutes of Health contrasted the industry’s response to Zika with its slow reaction to previous epidemics, particularly Ebola.
“We had been working on an Ebola vaccine for 10 years and had no interest from industry,” said Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases. “We made a West Nile vaccine several years ago but couldn’t find a pharmaceutical partner.